Skip to main content

Shopping Cart

You're getting the VIP treatment!

Item(s) unavailable for purchase
Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.
itemsitem
itemsitem

Recommended For You

Loading...
  • Biopharma in China

    Innovation, Trends and Dealmaking

    by Sven Agten, Ben Wu ...
    Series series Economics and Finance (R0)
    This book provides an insider’s overview of the emerging Chinese biopharma sector, its dynamics and trends, first bust and boom cycle, long-term perspectives, and how as a foreign company or investor to tap into this. China has gone from a country with no innovation in drug discovery, to a country which starts to out-license its biopharma technology to the rest of the world. The Chinese biopharma ... Read more

    $40.49 USD

People who read this also enjoyed

  • Building Biotechnology

    Biotechnology Business, Regulations, Patents, Law, Policy and Science

    by Yali Friedman ...
    Building Biotechnology helps readers understand the business of biotechnology, how to start and manage biotechnology companies, and how to better service the needs of biotechnology companies. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope. In addition to its popularity among ... Read more

    $53.99 USD

  • Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services

    Is your portfolio in peak health?Ranking among the world's largest markets, the $2.5 trillion health care industry is growing at an unprecedented rate. According to Miller Tabak + Co.'s health care strategist Les Funtleyder, major structural renovations to the system are imminent. “Health care is entering an era of reform,” Funtleyder writes, “and with reform comes change and the opportunity for ... Read more

    $48.99 USD

  • From Breakthrough to Blockbuster

    The Business of Biotechnology

    Financial Times Business Top Title March 2022 How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world's most breathtakingly expensive and highly regulated industries? Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these ... Read more

    $25.69 USD

  • Healthcare Disrupted

    Next Generation Business Models and Strategies

    “During a time of tremendous change and uncertainty, Healthcare Disrupted gives executives a framework and language to determine how they will evolve their products, services, and strategies to flourish in a increasingly value-based healthcare system. Using a powerful mix of real world examples and unanswered questions, Elton and O’Riordan lead you to see that ‘no action’ is not an option—and push ... Read more

    $21.00 USD

  • Frontiers in Market Access

    by Kasem Akhras ...
    The book is divided into eight chapters that covers key aspects of pharmaceutical market access in emerging markets. From understanding the healthcare environment, to the personal and organizational mindset, to pricing, market access solutions and negotiations. The book is based on practical experience that gives the reader knowledge and know-how to apply practical market access solutions to ... Read more

    $11.99 USD

  • The U.S. Healthcare Ecosystem: Payers, Providers, Producers

    An Essential Guide to the Processes and Operational Complexities of the U.S. Healthcare SystemA Doody's Core Title for 2024 & 2023!The U.S. Healthcare Ecosystem serves as an expert navigator through the complicated and often confusing environment where healthcare payers, healthcare providers, and producers of healthcare technologies all interact. This thorough resource provides expert insight and ... Read more

    $68.99 USD

  • Fundamentals of Market Access for Pharmaceuticals

    ”Because at the heart of the apparent conflict between public health concerns and capitalistic interests, market access for pharmaceuticals is largely driven by political considerations, the difference with usual consumer goods being that pharmaceuticals are saving lives or years of life in good health”.If pharmaceutical companies are to innovate, they must be incentivised with prices that reflect ... Read more

    $40.49 USD

  • Supply Chain in the Pharmaceutical Industry

    Strategic Influences and Supply Chain Responses

    by Rob Whewell ...
    The pharmaceutical and healthcare industry is hugely complex because it involves so many markets, products, processes and intermediaries. It is also heavily regulated, global, and used by everyone at some stage in their life. No wonder the supply chain for delivery of healthcare services is often fragmented and understood only in discrete sections. Changes in one area impact upon the others, and ... Read more

    $58.99 USD

  • Massively Better Healthcare

    The Innovator's Guide to Tackling Healthcare's Biggest Challenges

    by Halle Tecco ...
    “Halle Tecco wanted to see tech used for better medical services and getting people engaged in their own health. Now, she’s written a book on how she went about it.”—Wall Street Journal"For anyone who invests in health, works in health tech or simply cares about where this industry is headed, this is a smart and necessary read."—Entrepreneur"One of the most accessible... ... Read more

    $28.79 USD

  • Licensing, Selling and Finance in the Pharmaceutical and Healthcare Industries

    The Commercialization of Intellectual Property

    by Martin Austin ...
    Licensing, Selling and Finance in the Pharmaceutical and Healthcare Industries is an assessment of the turbulent state of pharmaceutical and biotechnology markets as we enter the second decade of the 21st Century. At the same time, the book offers a cautionary evaluation of the future financing of innovation in terms of what's gone wrong and how to succeed in the future. Martin Austin explores the ... Read more

    $58.99 USD

  • The Business of Healthcare Innovation

    Edited by Lawton Robert Burns ...
    The Business of Healthcare Innovation is a wide-ranging analysis of business trends in the manufacturing segment of the healthcare industry. It provides a thorough overview and introduction to the innovative sectors fueling improvements in healthcare: pharmaceuticals, biotechnology, platform technology, medical devices and information technology. For each sector, the book examines the basis and ... Read more

    $45.99 USD